ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
暂无分享,去创建一个
V. de Lédinghen | P. Marcellin | S. Chevret | D. Ouzan | S. Pol | D. Roulot | P. Nahon | N. Ganne-Carrié | A. Sutton | R. Moirand | D. Guyader | J. Blanc | F. Oberti | D. Larrey | G. Perlemuter | M. Bourlière | P. Mathurin | P. Calès | C. Christidis | T. Antonini | J. Péron | L. Alric | L. Serfaty | J. Zarski | G. Riachi | I. Ollivier-Hourmand | C. Pilette | A. Louvet | L. D'alteroche | N. Barget | Y. Repessé | A. Abergel | P. Attali | V. Di Martino | J. Henrion | E. Nguyen-Khac | C. Silvain | B. Bernard-Chabert | J. Grangé | X. Amiot | T. Dao | O. Goria | C. Wartelle | I. Archambeaud | V. Ozenne | C. Chaffaut | S. Hillaire | C. Moreno | J. Bronowicki | F. Zoulim | D. Thabut | N. Carbonell | Tt N Nguyen | A. Tran | A. Mallat | Y. Repesse | M. Bourliere | L. D’alteroche | Tt N Nguyen
[1] G. Tosetti,et al. AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit? , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[2] M. Trauner,et al. The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[3] Alihan Oral,et al. Prognostic role of ABO blood group and Rhesus factor in cirrhotic patients with hepatocellular carcinoma , 2019, Scientific Reports.
[4] V. de Lédinghen,et al. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis. , 2018, Journal of hepatology.
[5] S. Biggins,et al. Neutrophil‐to‐Lymphocyte Ratio Associates Independently With Mortality in Hospitalized Patients With Cirrhosis , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] X. Qi,et al. ABO blood type and risk of hepatocellular carcinoma: a meta-analysis , 2018, Expert review of gastroenterology & hepatology.
[7] A. Lebreton,et al. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis , 2018, Journal of thrombosis and haemostasis : JTH.
[8] D. Bauer,et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity , 2018, Alimentary Pharmacology and Therapeutics.
[9] L. Christou,et al. High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis , 2016, Hepatology.
[10] P. James,et al. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms , 2016, Journal of thrombosis and haemostasis : JTH.
[11] H. Ullum,et al. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors. , 2016, Circulation.
[12] C. Fondevila,et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[13] A. Hofman,et al. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: The Rotterdam Study. , 2015, Journal of hepatology.
[14] V. de Lédinghen,et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort) , 2015, Hepatology.
[15] S. Chevret,et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: Results of a longitudinal study , 2015, Hepatology.
[16] W. Ageno,et al. ABO Blood Group and Vascular Disease: An Update , 2013, Seminars in Thrombosis & Hemostasis.
[17] B. Nordestgaard,et al. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type , 2013, Canadian Medical Association Journal.
[18] E. Gómez,et al. The natural history of compensated HCV-related cirrhosis: a prospective long-term study. , 2013, Journal of hepatology.
[19] D. Valla,et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. , 2012, Gastroenterology.
[20] W. Ageno,et al. Non-O Blood Type Is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the Literature , 2012, Seminars in Thrombosis & Hemostasis.
[21] S. Roman,et al. Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests , 2010, European journal of gastroenterology & hepatology.
[22] J. O’Donnell,et al. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? , 2006, Transfusion.
[23] P. Böelle,et al. Association Between ABO Blood Group and Fibrosis Severity in Chronic Hepatitis C Infection , 2006, Digestive Diseases and Sciences.
[24] P. D. de Groot,et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity , 2006, Hepatology.
[25] P. Whincup,et al. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. , 2005, Atherosclerosis.
[26] D. Bowen,et al. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13 , 2003, Journal of thrombosis and haemostasis : JTH.
[27] S. Olliff,et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. , 2000, Transplantation.
[28] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[29] V. Arroyo,et al. Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.